Takafumi Furumoto
Nagasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Comparison of clinical characteristics and cytogenetic abnormalities between myelodysplastic syndromes in Nagasaki atomic bomb survivors and therapy-related myelodysplastic syndromes
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Multifocal motor neuropathy following allogeneic hematopoietic stem cell transplantation for mixed-phenotype acute leukemia
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 07, 2025
Improvement in survival of patients with higher risk but not lower risk myelodysplastic syndromes over 20 years: A retrospective study from Nagasaki, Japan.
Journal: British journal of haematology
Published: September 30, 2025
Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine Monotherapy.
Journal: Internal medicine (Tokyo, Japan)
Published: July 09, 2025
Donor lymphocyte infusion-based therapy for relapsed adult T-cell leukemia/lymphoma after HLA-haploidentical hematopoietic stem cell transplantation.
Journal: Transplant immunology
Published: March 20, 2025
RAISING revealed a heterogenous pattern of HTLV-1 clonality after HLA-haploidentical peripheral blood stem cell transplantation for ATL.
Journal: Leukemia & lymphoma
Published: November 01, 2023
Clinical features of non-infectious pulmonary complications after donor lymphocyte infusion in post-transplant patients: The Nagasaki Transplant Group Experience.
Journal: Transplant immunology
Published: June 11, 2022
Successful treatment of myelodysplastic syndromes complicated by myeloid sarcoma with haploidentical allogeneic hematopoietic stem cell transplantation using post-transplant cyclophosphamide
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 06, 2022
Warm autoimmune hemolytic anemia accompanied by metachronous double primary cancer
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 01, 2022
The response-guided ATG treatment provides a survival benefit and KPS recovery for patients with steroid refractory acute GVHD: The Nagasaki Transplant Group Experience.
Journal: Transplant immunology
Published: March 13, 2021
Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group.
Journal: International journal of hematology
Published: October 21, 2020
Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group.
Journal: International journal of hematology
Published: February 17, 2020
Last Updated: 09/26/2026